These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 35063302

  • 21. Blood Pressure Measurement: A KDOQI Perspective.
    Drawz PE, Beddhu S, Kramer HJ, Rakotz M, Rocco MV, Whelton PK.
    Am J Kidney Dis; 2020 Mar; 75(3):426-434. PubMed ID: 31864820
    [Abstract] [Full Text] [Related]

  • 22. Potential implications of the 2021 KDIGO blood pressure guideline for adults with chronic kidney disease in the United States.
    Foti KE, Wang D, Chang AR, Selvin E, Sarnak MJ, Chang TI, Muntner P, Coresh J.
    Kidney Int; 2021 Mar; 99(3):686-695. PubMed ID: 33637204
    [Abstract] [Full Text] [Related]

  • 23. Blood pressure in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
    Cheung AK, Chang TI, Cushman WC, Furth SL, Ix JH, Pecoits-Filho R, Perkovic V, Sarnak MJ, Tobe SW, Tomson CRV, Cheung M, Wheeler DC, Winkelmayer WC, Mann JFE, Conference Participants.
    Kidney Int; 2019 May; 95(5):1027-1036. PubMed ID: 31010478
    [Abstract] [Full Text] [Related]

  • 24. Suboptimal blood pressure control in chronic kidney disease stage 3: baseline data from a cohort study in primary care.
    Fraser SD, Roderick PJ, McIntyre NJ, Harris S, McIntyre CW, Fluck RJ, Taal MW.
    BMC Fam Pract; 2013 Jun 24; 14():88. PubMed ID: 23800117
    [Abstract] [Full Text] [Related]

  • 25. Canadian Society of Nephrology commentary on the KDIGO clinical practice guideline for CKD evaluation and management.
    Akbari A, Clase CM, Acott P, Battistella M, Bello A, Feltmate P, Grill A, Karsanji M, Komenda P, Madore F, Manns BJ, Mahdavi S, Mustafa RA, Smyth A, Welcher ES.
    Am J Kidney Dis; 2015 Feb 24; 65(2):177-205. PubMed ID: 25511161
    [Abstract] [Full Text] [Related]

  • 26. Summary of KDIGO guideline. What do we really know about management of blood pressure in patients with chronic kidney disease?
    Wheeler DC, Becker GJ.
    Kidney Int; 2013 Mar 24; 83(3):377-83. PubMed ID: 23325075
    [Abstract] [Full Text] [Related]

  • 27. Cardiovascular Implications of the 2021 KDIGO Blood Pressure Guideline for Adults With Chronic Kidney Disease.
    Lee HH, Lee H, Townsend RR, Kim DW, Park S, Kim HC.
    J Am Coll Cardiol; 2022 May 03; 79(17):1675-1686. PubMed ID: 35483755
    [Abstract] [Full Text] [Related]

  • 28. Indian commentary on the 2009 KDIGO clinical practice guideline for the diagnosis, evaluation, and treatment of chronic kidney disease-mineral and bone disorders.
    Jha V, Kher V, Pisharody R, Sharma RK, Abraham G, Gokulnath, Almeida A, Gupta A.
    Indian J Nephrol; 2011 Jul 03; 21(3):143-51. PubMed ID: 21886971
    [Abstract] [Full Text] [Related]

  • 29. KDOQI US commentary on the KDIGO clinical practice guideline for the prevention, diagnosis, evaluation, and treatment of hepatitis C in CKD.
    Gordon CE, Balk EM, Becker BN, Crooks PA, Jaber BL, Johnson CA, Michael MA, Pereira BJ, Uhlig K, Levin A.
    Am J Kidney Dis; 2008 Nov 03; 52(5):811-25. PubMed ID: 18971009
    [Abstract] [Full Text] [Related]

  • 30. Executive summary of the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease: known knowns and known unknowns.
    Levin A, Ahmed SB, Carrero JJ, Foster B, Francis A, Hall RK, Herrington WG, Hill G, Inker LA, Kazancıoğlu R, Lamb E, Lin P, Madero M, McIntyre N, Morrow K, Roberts G, Sabanayagam D, Schaeffner E, Shlipak M, Shroff R, Tangri N, Thanachayanont T, Ulasi I, Wong G, Yang CW, Zhang L, Robinson KA, Wilson L, Wilson RF, Kasiske BL, Cheung M, Earley A, Stevens PE.
    Kidney Int; 2024 Apr 03; 105(4):684-701. PubMed ID: 38519239
    [Abstract] [Full Text] [Related]

  • 31. [Recommended intakes of protein and energy in patients with chronic kidney disease: from guidelines of KDOQI and KDIGO in 2020].
    Cheng GP, Shi YY, Liu J, Zeng XQ, Liu Y.
    Zhonghua Yi Xue Za Zhi; 2021 May 18; 101(18):1287-1290. PubMed ID: 34015869
    [Abstract] [Full Text] [Related]

  • 32. Diabetes Management in Chronic Kidney Disease: Synopsis of the KDIGO 2022 Clinical Practice Guideline Update.
    Navaneethan SD, Zoungas S, Caramori ML, Chan JCN, Heerspink HJL, Hurst C, Liew A, Michos ED, Olowu WA, Sadusky T, Tandon N, Tuttle KR, Wanner C, Wilkens KG, Craig JC, Tunnicliffe DJ, Tonelli M, Cheung M, Earley A, Rossing P, de Boer IH, Khunti K.
    Ann Intern Med; 2023 Mar 18; 176(3):381-387. PubMed ID: 36623286
    [Abstract] [Full Text] [Related]

  • 33. Canadian Society of Nephrology commentary on the 2012 KDIGO Clinical Practice Guideline for Anemia in CKD.
    Moist LM, Troyanov S, White CT, Wazny LD, Wilson JA, McFarlane P, Harwood L, Sood MM, Soroka SD, Bass A, Manns BJ.
    Am J Kidney Dis; 2013 Nov 18; 62(5):860-73. PubMed ID: 24054466
    [Abstract] [Full Text] [Related]

  • 34. Blood pressure control in patients with chronic kidney disease.
    Lee JY, Han SH.
    Korean J Intern Med; 2021 Jul 18; 36(4):780-794. PubMed ID: 34153181
    [Abstract] [Full Text] [Related]

  • 35. Dipping Status, Ambulatory Blood Pressure Control, Cardiovascular Disease, and Kidney Disease Progression: A Multicenter Cohort Study of CKD.
    Borrelli S, Garofalo C, Gabbai FB, Chiodini P, Signoriello S, Paoletti E, Ravera M, Bussalino E, Bellizzi V, Liberti ME, De Nicola L, Minutolo R.
    Am J Kidney Dis; 2023 Jan 18; 81(1):15-24.e1. PubMed ID: 35709922
    [Abstract] [Full Text] [Related]

  • 36. Using pharmacists to improve risk stratification and management of stage 3A chronic kidney disease: a feasibility study.
    Chang AR, Evans M, Yule C, Bohn L, Young A, Lewis M, Graboski E, Gerdy B, Ehmann W, Brady J, Lawrence L, Antunes N, Green J, Snyder S, Kirchner HL, Grams M, Perkins R.
    BMC Nephrol; 2016 Nov 08; 17(1):168. PubMed ID: 27825313
    [Abstract] [Full Text] [Related]

  • 37. KDOQI US commentary on the 2012 KDIGO Clinical Practice Guideline for Anemia in CKD.
    Kliger AS, Foley RN, Goldfarb DS, Goldstein SL, Johansen K, Singh A, Szczech L.
    Am J Kidney Dis; 2013 Nov 08; 62(5):849-59. PubMed ID: 23891356
    [Abstract] [Full Text] [Related]

  • 38. Adaptation and implementation of the "Kidney Disease: Improving Global Outcomes (KDIGO)" guidelines for evaluation and management of mineral and bone disorders in chronic kidney disease for practice in the Middle East countries.
    Al Rukhaimi M, Al Sahow A, Boobes Y, Goldsmith D, Khabouth J, El Baz T, Mahmoud H, Ganji MR, Shaheen FA, Kidney Disease: Improving Global Outcomes.
    Saudi J Kidney Dis Transpl; 2014 Jan 08; 25(1):133-48. PubMed ID: 24434398
    [Abstract] [Full Text] [Related]

  • 39. A European Renal Best Practice (ERBP) position statement on the Kidney Disease: Improving Global Outcomes (KDIGO) clinical practice guideline for the management of blood pressure in non-dialysis-dependent chronic kidney disease: an endorsement with some caveats for real-life application.
    Verbeke F, Lindley E, Van Bortel L, Vanholder R, London G, Cochat P, Wiecek A, Fouque D, Van Biesen W.
    Nephrol Dial Transplant; 2014 Mar 08; 29(3):490-6. PubMed ID: 24071661
    [Abstract] [Full Text] [Related]

  • 40. Canadian Society of Nephrology Commentary on the Kidney Disease Improving Global Outcomes 2017 Clinical Practice Guideline Update for the Diagnosis, Evaluation, Prevention, and Treatment of Chronic Kidney Disease-Mineral and Bone Disorder.
    Holden RM, Mustafa RA, Alexander RT, Battistella M, Bevilacqua MU, Knoll G, Mac-Way F, Reslerova M, Wald R, Acott PD, Feltmate P, Grill A, Jindal KK, Karsanji M, Kiberd BA, Mahdavi S, McCarron K, Molnar AO, Pinsk M, Rodd C, Soroka SD, Vinson AJ, Zimmerman D, Clase CM.
    Can J Kidney Health Dis; 2020 Mar 08; 7():2054358120944271. PubMed ID: 32821415
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.